See on Scoop.itePharma

According to the NY Times “The Food and Drug Administration plans to loosen the rules for approving new treatments for Alzheimer’s disease. Drugs in clinical trial would qualify for approval if peo…
See on worldofdtcmarketing.com

Advertisements